Glucose News and Research

RSS

Low vitamin D levels associated with higher degrees of insulin resistance

A recent study of obese and non-obese children found that low vitamin D levels are significantly more prevalent in obese children and are associated with risk factors for type 2 diabetes. This study was accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

5 Dec 2011

FDA guides novel diabetes device manufacturers towards easier approval

The U.S. Food and Drug Administration (FDA) has issued a rule book for scientists and device manufacturers who are working towards an artificial pancreas – a portable device to help people with type 1 diabetes control their blood sugar levels.

4 Dec 2011

Obstacles people with type 2 diabetes face that prevent them from getting ultimate treatment

Eli Lilly and Company today announced it is conducting the first major international, prospective observational study designed to understand the real-world obstacles that people with type 2 diabetes face that prevent them from reaching their ultimate treatment goals.

2 Dec 2011

New insight into why aminoglycoside antibiotics cause deafness

Peter Steyger's research on hearing is very personal. That's because Steyger - a research scientist with the Oregon Hearing Research Center at Oregon Health & Science University - is deaf. Now Steyger has published groundbreaking research that is as personal as it gets. The study gives scientists new insight into why a specific class of antibiotics causes deafness - the same class of antibiotics that caused Steyger's deafness as a child in England 48 years ago. The study was published this month in Scientific Reports, part of the Nature Publishing Group.

2 Dec 2011

GE Healthcare invests in C8 MediSensors to focus on disease management solutions

GE Capital and GE Healthcare, the financial services and healthcare divisions of General Electric Company, announced today an investment in C8 MediSensors, Inc., a privately held developer of non-invasive continuous glucose monitors for diabetic patients.

2 Dec 2011

JDRF supports FDA's draft guidance on artificial pancreas technology

The JDRF today said it is encouraged that the Food and Drug Administration (FDA) has issued a draft guidance which appears to lay a foundation for accelerating the development and availability of artificial pancreas technology (AP) that will improve the lives of millions of Americans living with type 1 diabetes.

2 Dec 2011

FDA issues draft guidance on artificial pancreas system

The U.S. Food and Drug Administration today issued draft guidance designed to help investigators and manufacturers as they develop and seek approval for artificial pancreas device systems to treat type 1 diabetes.

2 Dec 2011

Life as a couch potato can create new fat in fat cells

Conventional wisdom says that exercise is a key to weight loss - a no-brainer. But now, Tel Aviv University researchers are revealing that life as a couch potato, stretched out in front of the TV, can actually be "active inactivity" - and cause you to pack on the pounds.

2 Dec 2011

Low-carbohydrate diet may help prepubescent girls avoid obesity associated risks

A low-carbohydrate diet may help prepubescent girls avoid some risks associated with obesity, such as diabetes and heart disease, according to research from the University of Alabama at Birmingham.

2 Dec 2011

Elevated blood sugar levels linked with increased risk of colorectal cancer

Elevated blood sugar levels are associated with an increased risk of colorectal cancer, according to a study led by researchers at Albert Einstein College of Medicine of Yeshiva University.

30 Nov 2011

FDA grants 510(k) clearance for SweetSpot Diabetes Data Management Service

SweetSpot Diabetes Care, Inc. announced today it has received 510(k) clearance from the United States Food & Drug Administration (FDA) for the SweetSpot Diabetes Data Management Service which helps health care providers and patients see, understand and use blood glucose meter data to diagnose and manage diabetes.

29 Nov 2011

Peninsula Foundation secures funding for PCOS and diabetes research

The Peninsula Foundation, the charitable arm of the Peninsula College of Medicine and Dentistry, has secured funding of -15,000 from The Duchy Health Charity for research into Polycystic Ovary Syndrome (PCOS) and diabetes. The research led, by Professor Jonathan Pinkney at the Knowledge Spa campus in Truro, will be the first non commercial medical research to be carried out at the site.

29 Nov 2011

A very low calorie diet can effectively cure type 2 diabetes mellitus

A low-calorie diet eliminates insulin dependence and leads to improved heart function in obese patients with type 2 diabetes, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

28 Nov 2011

Transplantation of new neurons into damaged area of the brain could restore brain functions

Without neurons reacting to the blood leptin level, the brain does not control the feeling of hunger and fullness. This type of genetic defects results in severe obesity in humans and animals.

25 Nov 2011

Researchers take a step toward neuronal replacement therapy

A new study has revealed that immature neurons taken from healthy mouse embryos can repair damaged brain circuitry and partially normalize metabolism when transplanted into adult mice that have grown morbidly obese due to a genetic deficiency.

24 Nov 2011

Carefully selected young, healthy neurons can repair brain circuitry

Neuron transplants have repaired brain circuitry and substantially normalized function in mice with a brain disorder, an advance indicating that key areas of the mammalian brain are more reparable than was widely believed.

24 Nov 2011

Benefits of vitamin D-fortified yoghurt drink for people with diabetes

People with diabetes are known to have an increased risk of heart disease. New research published in BioMed Central's open access journal BMC Medicine shows that regular consumption of a vitamin D-fortified yoghurt drink improves cholesterol levels and biomarkers of endothelial dysfunction, a precursor of heart disease, in diabetics.

24 Nov 2011

Study looks at effects of antipsychotic drugs on two brain receptors linked to schizophrenia

Researchers from Mount Sinai School of Medicine, have identified the pattern of cell signaling induced by antipsychotic drugs in a complex composed of two brain receptors linked to schizophrenia.

24 Nov 2011

Takeda submits alogliptin plus metformin NDA to FDA for treatment of type 2 diabetes

Takeda Pharmaceutical Company Limited (Takeda) announced today that its wholly-owned subsidiary Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for the fixed-dose combination therapy alogliptin/metformin, which combines alogliptin with metformin in a single tablet.

24 Nov 2011

Treatment of Type 1 diabetes patients with DiaPep277- may have several medical benefits

The clinical trial was random, regulated, double-blinded and broad-based. The drug was tested on 457 patients, aged 16-45, who had been diagnosed with Type 1 diabetes a short time before joining the trial. The trial took place in around 40 medical centers in Europe, Israel and South Africa. The patients in the trial were randomly assigned to one of two groups: One received the trial drug (DiaPep277-) through a subcutaneous injection once every three months, for a period of two years, while the control group was given a placebo in the same way.

23 Nov 2011